Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
about
Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of LiteratureTreatment sequence in castration-resistant prostate cancer: A retrospective study in the new anti-androgen era.Multifaceted and personalized therapy of advanced prostate cancer.Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.[Antihormonal therapy in prostate cancer : Side effects].[Splice variant AR-V7 : Is it time for its routine use as a predictive marker in prostate cancer?]
P2860
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic parameters for resp ...... nts; a possible time relation.
@en
type
label
Prognostic parameters for resp ...... nts; a possible time relation.
@en
prefLabel
Prognostic parameters for resp ...... nts; a possible time relation.
@en
P2093
P2860
P356
P1433
P1476
Prognostic parameters for resp ...... nts; a possible time relation.
@en
P2093
Alfons J M van den Eertwegh
Andries M Bergman
Dutch Uro-Oncology Studygroup
Emile D Kerver
Fabienne Warmerdam
Hans Gelderblom
Hendrik P van den Berg
Igle J de Jong
John B Haanen
Jules L L M Coenen
P2860
P356
10.1002/PROS.23094
P577
2015-09-22T00:00:00Z